Originally published by our sister publication Pharmacy Practice News
By Ethan Covey
Due to multiple factors, immigrants living in the United States who have chronic hepatitis B virus (HBV) are vulnerable to gaps in antiviral use. This can increase their risk for serious outcomes, according to a study presented at IDWeek 2024, held in Los Angeles (poster P-2184).
“Liver disease and cancer due to hepatitis B are important health disparities affecting Asian, African and Latino immigrants in